Jun 2026 (Q2 FY26) — Jul 31, 2026
Corteva Q2 FY26 — Strong First Half Performance and Raised Full-Year Outlook
Read the full callCorteva (CTVA) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Corteva earnings: last reported Fri, 31 Jul 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 6,379 | −1.2% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | Operating profit / revenue | Quarter to Jun 2026 | Not in the filed figures for the quarter to jun 2026. No older figure is substituted. | ||
| Net profit | 1,161 | −11.6% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Guidance
What management said, and what became of it
23 of 25 judged targets kept · 32 open · verdicts reflect calls analysed to Jun 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| Public filing of the Form 10 | public filing towards the end of the second quarter | Mar 2026 | completed key leadership appointments, publicly filed the Form 10, appointed both Boards of Directors | Achieved |
| Share repurchases | approximately $500 million | Dec 2025 | no mention of share repurchases anywhere in the Q2/1H FY26 call | Ghosted |
| Conkesta E3 trait penetration in Brazil | cross into double-digit penetration | Sep 2025 | we think we're going to be high single digits, low double digits in terms of penetration in the market with Conkesta E3 in 2027 | At Risk |
2 of Corteva, Inc.'s 57 targets were missed. See which ones, and which are quietly gone. The 3 above are the free sample; 54 more targets are in the full ledger.
Claimed
- Net sales increased 4% in the first half of 2026 to $11.3 billion.
- Operating EBITDA increased 10% in the first half of 2026 to $3.7 billion.
- Operating EPS increased 14% in the first half of 2026.
- Full-year operating EBITDA guidance raised to $4.1 billion to $4.3 billion, representing 9% growth at midpoint.
- Full-year operating EPS guidance raised to $3.60 to $3.80 per share, representing 11% growth at midpoint.
Qualified
- Crop Protection pricing remained under pressure due to competitive market dynamics, particularly in Latin America, declining low single digits in H1.
- Expected Crop Protection pricing to decline low to mid-single digits in H2.
- Credit is tight for Brazilian farmers, impacting order decisions closer to planting time.
- Residual dyssynergy impact of $25 million expected this year due to timing of separation activities.
Price
$12.65 −1.79% · −$0.23
Performance −79.4% 1Y
1Y: $61.4 on 17 Oct 2025 → $12.65. High $90.51 (29 Jul 2026), low $11.92 (2 Oct 2026).
- Previous close
- $12.88
- 52-week range
- $11.92 – $90.51
- One year
- −79.59%
Overview
- Symbol
- CTVA
- Sector
- Materials
- Exchange
- US
- Currency
- USD
Guidance
What management said, and what became of it
23 of 25 judged targets kept · 32 open · verdicts reflect calls analysed to Jun 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| Public filing of the Form 10 | public filing towards the end of the second quarter | Mar 2026 | completed key leadership appointments, publicly filed the Form 10, appointed both Boards of Directors | Achieved |
| Share repurchases | approximately $500 million | Dec 2025 | no mention of share repurchases anywhere in the Q2/1H FY26 call | Ghosted |
| Conkesta E3 trait penetration in Brazil | cross into double-digit penetration | Sep 2025 | we think we're going to be high single digits, low double digits in terms of penetration in the market with Conkesta E3 in 2027 | At Risk |
Claimed
- Net sales increased 4% in the first half of 2026 to $11.3 billion.
- Operating EBITDA increased 10% in the first half of 2026 to $3.7 billion.
- Operating EPS increased 14% in the first half of 2026.
- Full-year operating EBITDA guidance raised to $4.1 billion to $4.3 billion, representing 9% growth at midpoint.
- Full-year operating EPS guidance raised to $3.60 to $3.80 per share, representing 11% growth at midpoint.
Qualified
- Crop Protection pricing remained under pressure due to competitive market dynamics, particularly in Latin America, declining low single digits in H1.
- Expected Crop Protection pricing to decline low to mid-single digits in H2.
- Credit is tight for Brazilian farmers, impacting order decisions closer to planting time.
- Residual dyssynergy impact of $25 million expected this year due to timing of separation activities.
The full ledger
Open Corteva, Inc.’s full ledger
A free account opens 5 company ledgers a month. All 57 tracked commitments, with each call’s wording and source.
Call summaries
Mar 2026 (Q1 FY26) — May 6, 2026
Corteva Q1 FY26 — 21% EBITDA growth on broad Seed/CP volume gains, royalty-positive inflection and 'Vylor' spin name
Read the full callDec 2025 (Q4 FY25) — Feb 4, 2026
Corteva Q4 FY25 — Strong FY25 Performance, Strategic Bayer Agreement, and Positive 2026 Outlook
Read the full callEvery analysed call
Corteva earnings calls (CTVA)
Financials
What the filings say
Net profit, year on year: −12% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 2,326 | 3,978 | 4,417 | 6,456 | 2,618 | 3,910 | 4,905 | 6,379 |
| Other income | -107 | 19 | 15 | 103 | -23 | -665 | -117 | -115 |
| Profit before tax | -633 | 88 | 784 | 1,804 | -370 | -530 | 858 | 1,625 |
| Tax rate | 18.0% | 156.8% | 14.9% | 23.4% | 16.8% | −1.3% | 15.5% | 25.1% |
| Net profit | -524 | -41 | 652 | 1,314 | -320 | -552 | 720 | 1,161 |
| EPS ($ per share) | -0.76 | — | 0.95 | 1.92 | -0.47 | — | 1.07 | 1.73 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves | 0 | -425 | 0 | 524 | 250 | -41 | 55 | -67 |
| Total liabilities | 33,530 | 17,842 | 17,586 | 16,721 | 17,077 | 17,717 | 16,795 | 18,459 |
| Fixed assets | 4,544 | 4,546 | 4,396 | 4,329 | 4,254 | 4,287 | 4,099 | 4,220 |
| Investments | 5 | 5 | 269 | 86 | 124 | 98 | 63 | 9 |
| Total assets | 108,683 | 42,397 | 42,649 | 42,344 | 42,618 | 42,996 | 40,825 | 42,845 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 483 | 1,070 | 2,064 | 2,727 | 872 | 1,769 | 2,145 | 3,406 |
| Cash from investing | -505 | -904 | -674 | -362 | -632 | -1,987 | -589 | -543 |
| Cash from financing | -2,624 | -2,929 | 303 | -1,266 | -1,180 | -99 | -1,199 | -1,644 |
| Net cash flow | -2,890 | -2,851 | 1,700 | 963 | -1,218 | -460 | 264 | 1,303 |
| Capital expenditure | -1,501 | -1,163 | -475 | -573 | -605 | -595 | -597 | -591 |
| Free cash flow | -1,018 | -93 | 1,589 | 2,154 | 267 | 1,174 | 1,548 | 2,815 |
CTVA revenue by segment
Crop Protection shrank from 70% to 29% of revenue over the last two years.
| Segment | Q3 FY2024 | Q4 FY2024 | Q1 FY2025 | Q2 FY2025 | Q3 FY2025 | Q4 FY2025 | Q1 FY2026 | Q2 FY2026 | YoY growth latest quarter |
|---|---|---|---|---|---|---|---|---|---|
| Seed | 30% | 45% | 61% | 70% | 35% | 44% | 62% | 71% | -0.1% |
| Crop Protection | 70% | 55% | 39% | 30% | 65% | 56% | 38% | 29% | -3.8% |
Share of consolidated revenue by quarter. Q4 is the fiscal year less its first three quarters.
See how segments are shifting across companies → Segment Shift
Revenue by region
Q2 FY2026 · share of revenue
- North America 71% ↑ 45 pt
- EMEA 11% ↓ 6 pt
- Latin America 11% ↓ 32 pt
- Asia Pacific 7% ↓ 7 pt
As CTVA cuts its regions in its filings; they can nest, so they need not add to 100%.
Insider filings
70 filings between Oct 31, 2025 and Oct 1, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$636.2K
2 sales by 1 insider
Compensation
not trading decisions- 35
- Award — granted as compensation
- 1
- Option exercise — converted options into shares
- 29
- Tax withheld — shares kept back by the company to cover tax
Also filed: 3 other filings.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| TITUS BRIAN | — | $636.2K | Feb 20, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 1, 2026 | TITUS BRIAN See Remarks | Other | 13,315 | $0 |
| Oct 1, 2026 | TITUS BRIAN See Remarks | Other | 11,083 | $0 |
| Oct 1, 2026 | KISSAM LUTHER C IV Chief Executive Officer | Other | 127,949 | $0 |
| Sep 16, 2026 | Johnson David Paul EVP, Chief Financial Officer | Tax withheld | 8,517 | $690.0K |
| Sep 15, 2026 | Johnson Jennifer Amy SVP, Chief Legal Officer | Tax withheld | 446 | $37.2K |
| Jul 31, 2026 | Nayyar Nayaki R Director | Award | 413 | $32.5K |
| Jul 31, 2026 | Policinski Christopher J. Director | Award | 413 | $32.5K |
| Jul 31, 2026 | Giesselman Janet Plaut Director | Award | 98 | $7.7K |
| Jun 1, 2026 | KISSAM LUTHER C IV CEO, Crop Protection Business | Award | 24,138 | $0 |
| Apr 30, 2026 | Nayyar Nayaki R Director | Award | 401 | $32.5K |
| Apr 30, 2026 | Giesselman Janet Plaut Director | Award | 96 | $7.7K |
| Apr 30, 2026 | Engel Klaus A Director | Tax withheld | 906 | $73.4K |
| Apr 30, 2026 | Lutz Marcos M Director | Tax withheld | 906 | $73.4K |
| Apr 28, 2026 | Giesselman Janet Plaut Director | Award | 2,350 | $0 |
| Apr 28, 2026 | Lutz Marcos M Director | Award | 2,350 | $0 |
| Apr 28, 2026 | Policinski Christopher J. Director | Award | 2,350 | $0 |
| Apr 28, 2026 | Preete Kerry J Director | Award | 2,350 | $0 |
| Apr 28, 2026 | Ward Pat Director | Award | 2,350 | $0 |
| Apr 28, 2026 | EVERITT DAVID C Director | Award | 2,350 | $0 |
| Apr 28, 2026 | Gilson Jean-Marc Director | Award | 2,350 | $0 |
| Apr 28, 2026 | Engel Klaus A Director | Award | 2,350 | $0 |
| Apr 28, 2026 | PAGE GREGORY R Director | Award | 3,870 | $0 |
| Apr 28, 2026 | Grimes Karen H. Director | Award | 2,350 | $0 |
| Apr 28, 2026 | Nayyar Nayaki R Director | Award | 2,350 | $0 |
| Feb 28, 2026 | TITUS BRIAN See Remarks | Tax withheld | 111 | $8.9K |
| Feb 28, 2026 | Grimm Audrey SVP, Chief People Officer | Tax withheld | 285 | $22.8K |
| Feb 28, 2026 | Magro Charles V. Chief Executive Officer | Tax withheld | 4,958 | $397.2K |
| Feb 28, 2026 | Eathington Samuel R See Remarks | Tax withheld | 471 | $37.7K |
| Feb 28, 2026 | O'Connor Judd M EVP, Seed Business Unit | Tax withheld | 188 | $15.1K |
| Feb 28, 2026 | King Robert D. EVP, Crop Protection Business | Tax withheld | 574 | $46.0K |
| Feb 24, 2026 | Johnson Jennifer Amy SVP, Chief Legal Officer | Award | 12,922 | $0 |
| Feb 24, 2026 | O'Connor Judd M EVP, Seed Business Unit | Award | 14,173 | $0 |
| Feb 24, 2026 | King Robert D. EVP, Crop Protection Business | Award | 15,006 | $0 |
| Feb 24, 2026 | Eathington Samuel R See Remarks | Award | 14,173 | $0 |
| Feb 24, 2026 | Johnson David Paul EVP, Chief Financial Officer | Award | 24,112 | $0 |
| Feb 24, 2026 | Magro Charles V. Chief Executive Officer | Award | 108,376 | $0 |
| Feb 24, 2026 | TITUS BRIAN See Remarks | Award | 2,085 | $0 |
| Feb 24, 2026 | Grimm Audrey SVP, Chief People Officer | Award | 11,255 | $0 |
| Feb 20, 2026 | Magro Charles V. Chief Executive Officer | Tax withheld | 6,026 | $459.8K |
| Feb 20, 2026 | King Robert D. EVP, Crop Protection Business | Tax withheld | 576 | $44.0K |
| Feb 20, 2026 | TITUS BRIAN See Remarks | Sale | 4,000 | $306.1K |
| Feb 20, 2026 | TITUS BRIAN See Remarks | Sale | 4,311 | $330.1K |
| Feb 20, 2026 | TITUS BRIAN See Remarks | Option exercise | 4,311 | $218.6K |
| Feb 20, 2026 | TITUS BRIAN See Remarks | Tax withheld | 132 | $10.1K |
| Feb 20, 2026 | O'Connor Judd M EVP, Seed Business Unit | Tax withheld | 247 | $18.8K |
| Feb 20, 2026 | Grimm Audrey SVP, Chief People Officer | Tax withheld | 387 | $29.5K |
| Feb 20, 2026 | Eathington Samuel R See Remarks | Tax withheld | 572 | $43.6K |
| Feb 18, 2026 | TITUS BRIAN See Remarks | Tax withheld | 113 | $8.7K |
| Feb 18, 2026 | Grimm Audrey SVP, Chief People Officer | Tax withheld | 399 | $30.6K |
| Feb 18, 2026 | Magro Charles V. Chief Executive Officer | Tax withheld | 5,319 | $407.4K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Corteva, Inc.
Free account. Everything above stays public.
Write why you follow Corteva, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading
Other companies in Materials
Nearest to Corteva by market cap among the sector's top 20 companies at Q2 2026.